Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Franz Köhler Chemie is a specialized German pharmaceutical company focused on organ protection and preservation solutions. The company's most prominent product is Custodiol HTK, a multi-organ preservation solution used globally for heart, kidney, liver, and lung transplants, as well as for cardioplegia in cardiac surgery. In addition to its leadership in transplantation medicine, the company develops and manufactures products for intensive care, emergency medicine, and diagnostic imaging. Based in Alsbach-Hähnlein, the firm operates its own research and production facilities, maintaining a strong reputation for quality in the niche field of organ cold storage and protection. It remains a family-owned enterprise with a history dating back to 1959.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Custodiol.